{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,23]],"date-time":"2026-02-23T12:30:32Z","timestamp":1771849832555,"version":"3.50.1"},"reference-count":10,"publisher":"Wiley","license":[{"start":{"date-parts":[[2019,4,29]],"date-time":"2019-04-29T00:00:00Z","timestamp":1556496000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Dermatologic Therapy"],"DOI":"10.1111\/dth.12923","type":"journal-article","created":{"date-parts":[[2019,4,12]],"date-time":"2019-04-12T16:05:46Z","timestamp":1555085146000},"page":"e12923","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":35,"title":["Apremilast is effective in controlling the progression of adult vitiligo: A case series"],"prefix":"10.1155","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3780-6396","authenticated-orcid":false,"given":"Imran","family":"Majid","sequence":"first","affiliation":[{"name":"Department of DermatologyCUTIS Institute of Dermatology Srinagar Jammu and Kashmir India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saher","family":"Imran","sequence":"additional","affiliation":[{"name":"Department of DermatologyCUTIS Institute of Dermatology Srinagar Jammu and Kashmir India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sameena","family":"Batool","sequence":"additional","affiliation":[{"name":"Department of DermatologyCUTIS Institute of Dermatology Srinagar Jammu and Kashmir India"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2019,4,29]]},"reference":[{"issue":"2","key":"e_1_2_6_2_1","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.jaad.2017.01.052","article-title":"Long\u2010term safety and tolerability of apremilast in patients with psoriasis: Pooled safety analysis for\u2265 156 weeks from 2 phase 3, randomized, controlled trials (ESTEEM 1 and 2)","volume":"77","author":"Crowley J.","year":"2017","journal-title":"Journal of the American Academy of Dermatology."},{"key":"e_1_2_6_3_1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2017\/2386234","article-title":"Repigmentation of tenacious vitiligo on apremilast","volume":"2017","author":"Huff S. B.","year":"2017","journal-title":"Case Reports in Dermatological Medicine"},{"key":"e_1_2_6_4_1","first-page":"e12745","article-title":"Controversial issues in vitiligo patients: A review of old and recent treatments","volume":"1","author":"Lotti T.","year":"2018","journal-title":"Dermatologic Therapy"},{"issue":"2","key":"e_1_2_6_5_1","doi-asserted-by":"crossref","first-page":"124","DOI":"10.4103\/0019-5154.53185","article-title":"Childhood vitiligo: Response to methylprednisolone oral minipulse therapy and topical fluticasone combination","volume":"54","author":"Majid I.","year":"2009","journal-title":"Indian Journal of Dermatology."},{"issue":"1","key":"e_1_2_6_6_1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s40744-014-0005-4","article-title":"Apremilast: A phosphodiesterase 4 inhibitor for the treatment of psoriatic arthritis","volume":"1","author":"Mease P. J.","year":"2014","journal-title":"Rheumatology and Therapy."},{"issue":"21","key":"e_1_2_6_7_1","first-page":"343","article-title":"Interfering with the IFN\u2010\u03b3\/CXCL10 pathway to develop new targeted treatments for vitiligo","volume":"3","author":"Rashighi M.","year":"2015","journal-title":"Annals of Translational Medicine"},{"key":"e_1_2_6_8_1","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.jaad.2016.11.010","article-title":"Current and emerging treatments for vitiligo","volume":"77","author":"Rodrigues M.","year":"2017","journal-title":"Journal of the American Academy of Dermatology"},{"issue":"12","key":"e_1_2_6_9_1","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1016\/j.bcp.2012.01.001","article-title":"Apremilast mechanism of action and application to psoriasis and psoriatic arthritis","volume":"83","author":"Schafer P.","year":"2012","journal-title":"Biochemical Pharmacology"},{"issue":"4","key":"e_1_2_6_10_1","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1111\/j.1476-5381.2009.00559.x","article-title":"Apremilast, a cAMP phosphodiesterase\u20104 inhibitor, demonstrates anti\u2010inflammatory activity in vitro and in a model of psoriasis","volume":"159","author":"Schafer P. H.","year":"2010","journal-title":"British Journal of Pharmacology."},{"issue":"1","key":"e_1_2_6_11_1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s13555-013-0023-0","article-title":"Phosphodiesterase 4 inhibition in the treatment of psoriasis, psoriatic arthritis and other chronic inflammatory diseases","volume":"3","author":"Wittmann M.","year":"2013","journal-title":"Dermatology and Therapy"}],"container-title":["Dermatologic Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/dth.12923","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/dth.12923","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/dth.12923","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,23]],"date-time":"2022-12-23T18:01:02Z","timestamp":1671818462000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/dth.12923"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4,29]]},"references-count":10,"alternative-id":["10.1111\/dth.12923"],"URL":"https:\/\/doi.org\/10.1111\/dth.12923","archive":["Portico"],"relation":{},"ISSN":["1396-0296","1529-8019"],"issn-type":[{"value":"1396-0296","type":"print"},{"value":"1529-8019","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,4,29]]}}}